GSD Type IV with Neurogenic Bladder — What to Do When First-Line Emptying Therapy Has Not Worked
Neurogenic bladder is a recognised complication of glycogen storage disease type IV, presenting as urinary hesitancy, straining, slow stream, or difficulty fully emptying the bladder. When initial management does not achieve adequate urinary flow and emptying, a structured next-line approach is indicated.
First-line treatment — goal not met
Initial management of obstructive and emptying symptoms in this setting includes timed voiding, double voiding, optimising bowel function, pelvic floor muscle relaxation exercises, muscle relaxants, and a trial of alpha-blockers. When these measures fail to achieve improved urinary flow and emptying, escalation to the next line is warranted.
Next-step approach (partial overview)
The next line centres on a catheterisation-based strategy to ensure adequate bladder emptying. Which approach is used depends on the patient's individual circumstances. The full protocol specifies the preferred options and the clinical decision points between them.
References
DOI: 10.1016/j.ymgme.2023.107525
- For patients with hesitancy, straining, slow stream, or emptying difficulties, first-line treatments include timed voiding, double voiding (i.e., attempting to void again immediately after going), optimizing bowel function, and pelvic floor muscle exercises geared toward improving relaxation and tone (see Section 5.6).
- When emptying is not adequate, clean intermittent self-catheterization is recommended over placement of an indwelling catheter to decrease the risk of recurring UTI.
- If clean intermittent self-catheterization is not possible, one can consider a suprapubic catheter for ease of catheter exchanges; a suprapubic tube is preferred over a urethral catheter to minimize risk of urethral erosion.
View source ↗